Allen & Overy celebrates opening of Barcelona office

Friday, October 3, 2014

International law firm Allen & Overy formally celebrated the opening of its Barcelona offices yesterday evening at a private reception hosted by Wim Dejonghe, Global Managing Partner of Allen & Overy, for some 100 guests.

With Iberian headquarters in Madrid, Allen & Overy has been present in Spain for the past 23 years. The Barcelona office, which is Allen & Overy’s 44th office worldwide, brings the firm closer to its clients and bolsters its practice areas and presence both in Spain and across the global network. For Dejonghe, “We at Allen & Overy are convinced that the Spanish market offers opportunities for us to continue to grow at the rapid rate that we have been to date. This latest step allows us to anticipate our clients’ needs by identifying business channels in the local market, and to provide wider premium coverage for our global clients with interests in Spain”. More >>

Tags:  Allen & Overy LLP | Barcelona

UBM to Acquire Advanstar for $972 Million

Thursday, October 2, 2014

As reported in The Wall Street Journal, The New York Times and other media outlets, UBM plc announced that it has entered into a definitive agreement to acquire Paul, Weiss client Advanstar Communications for $972 million in cash. UBM is a U.K.-headquartered communications and events business. Advanstar operates 54 trade shows and over 100 conferences annually, including Magic Marketplace, the largest U.S. fashion trade show. The transaction, which is expected to close by year end, will make UBM the largest events business in the United States. More >>

Tags:  New York

Davis Polk Advises Morgan Stanley on AUD 650 Million Senior Notes Offering

Thursday, October 2, 2014

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of AUD 650 million aggregate principal amount of 5% fixed-rate senior registered notes due 2021. The underwriters were Morgan Stanley & Co. International plc, Australia and New Zealand Banking Group Limited, National Australia Bank Limited and Mitsubishi UFJ Securities International plc. More >>

Tags:  Davis Polk & Wardwell LLP | New York

Fragomen Worldwide Continues Global Expansion, Opens New Office in Kenya

Wednesday, October 1, 2014

Fragomen Worldwide, the world’s leading immigration service provider exclusively devoted to immigration, has further expanded its global presence with the opening of a new office in Nairobi, Kenya.

“As is the case with our new office in Kenya, Fragomen has long been committed to providing on-the-ground service in key international markets that best support our clients’ business goals,” said Austin T. Fragomen, Chairman of the firm’s Executive Committee. “Since opening our first international office in Brussels, we have steadily increased our international reach based on our clients’ needs, and now serve clients in major markets throughout Africa, the Americas, Asia Pacific, Europe and the Middle East.” More >>

Tags:  Fragomen, Del Rey, Bernsen & Loewy, LLP | Africa

Dentons advises Burgan Bank on US$500 million issuance

Wednesday, October 1, 2014

Dentons has advised Burgan Bank on the issuance of US$500 million Perpetual Tier 1 Capital Securities, which completed on 30 September 2014. The Capital Securities were listed on the Irish Stock Exchange and represented Kuwait’s first ever Basel III-compliant regulatory capital issuance. More >>

Tags:  Dentons | Dubai

Johnson & Johnson’s $1.75 Billion Acquisition of Alios BioPharma

Wednesday, October 1, 2014

Johnson & Johnson announced a definitive agreement to acquire Alios BioPharma, a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.75 billion in cash. Cravath represented Johnson & Johnson in the transaction. The closing is subject to clearance under the Hart‑Scott‑Rodino Antitrust Improvements Act and other customary closing conditions. The transaction is expected to close during the fourth quarter of 2014. More >>

Tags:  New York

Horizon Pharma Acquires Vidara Therapeutics and Enters Five-Year $300 Million Term Loan Facility

Wednesday, October 1, 2014

Cooley LLP announced today that it advised Horizon Pharma, Inc. on the completion of its acquisition of Vidara Therapeutics International plc. In connection with the acquisition, Horizon and Vidara have combined to form parent company Horizon Pharma plc, which is incorporated in Ireland. Concurrently with the acquisition, Horizon entered into a five-year $300 million term loan facility and related uncommitted facilities. More >>

Tags:  San Diego